Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2016

May 24, 2016

34395_dirs_2016-05-24_ba2837ac-c423-4dac-909b-9f9f6fc2aa9e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-20

Reporting Person: Innes Guy Archibald (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-20 Common Stock M 5000 $3 Acquired 1232741 Direct
2016-05-20 Common Stock F 4238 $3.54 Disposed 1228503 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-20 Stock Option (Right to Buy) $3 M 5000 Disposed 2016-05-25 Common Stock (5000) Direct

Footnotes

F1: Represents the aggregate amount of shares of VolitionRx Limited Common Stock disposed of in a cashless exercise.